Learn some of the key considerations for choosing ART for pediatric patients including for HIV exposed newborns, and children and adolescents infected with HIV.
Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.07 MB
Released: April 29, 2022
Acknowledgements
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare
Leaving the CCO site
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
